BeWonderNow, Inc. Opens Fall 2026 Pilot Grant Applications — Last Brain Cancer Research Funding Cycle of the Year

BeWonderNow Inc. Fall 2026 Pilot Grant Cycle Open

BeWonderNow, Inc. is proud to announce that applications are now open for its Fall 2026 Pilot Grant Program — the second and final brain cancer research funding cycle of the year. Building on a strong Spring 2026 cycle that awarded grants to researchers at Harvard Medical School, Johns Hopkins University School of Medicine, Emory University School of Medicine, and the Children’s Cancer Therapy Development Institute, BeWonderNow is ready to fund the next wave of bold, early-phase brain cancer science.

For researchers who missed the Spring window — or whose work is ready for a new submission — this is the last opportunity to apply for a BeWonderNow pilot grant in 2026.

Spring 2026 Grantees:
· Yoav Binenbaum, MD, PhD — Boston Children’s Cancer and Blood Disorders Center / Wyss Institute of Biologically Inspired Engineering, Harvard Medical School
· Laurie Delatour, MD, PhD — Johns Hopkins University School of Medicine
· Tomas Garon-Mvudi, MD — Emory University School of Medicine
· Anthony Haight, Ph.D. — Children’s Cancer Therapy Development Institute

Fall 2026 Submission Deadlines:
· Letter of Intent: September 7, 2026
· Full Proposal: October 5, 2026
· Funding Decision Announcement: November 9, 2026

Awards range from $25,000 to $150,000 in direct costs, supporting projects of 12 to 24 months in duration. Indirect costs are allowed up to 10%. The program is open to physician-scientists and researchers affiliated with accredited academic, medical, or research institutions in the United States.

Applications begin with a one-page Letter of Intent. The LOI is designed to be brief and accessible — a straightforward entry point that allows the BeWonderNow Board of Directors to assess mission alignment before inviting a full proposal. Applicants are notified of their invitation status within five business days of LOI submission.

“Every cycle, we are inspired by the quality and ambition of the research ideas that come through this program,” said Sandi Wewerka of BeWonderNow, Inc. “Our Spring 2026 grantees are already advancing work that could reshape how we understand and treat brain cancer. We are eager to fund the next chapter.”

Full proposals, submitted by invitation only following LOI review, must include a five-page proposal with optional appendix, budget and budget justification, NIH biosketches for all key personnel, a cover letter, and an AI use statement. Funding decisions for the Fall cycle will be announced November 9, 2026.

Interested researchers are encouraged to submit their Letter of Intent early. For complete eligibility requirements, application guidelines, and submission instructions, visit bwnfoundation.com/grant-information.

Questions about eligibility or program alignment should be directed to Sandi Wewerka at sandi@bwnfoundation.com or 651-357-3679.

———

BeWonderNow, Inc. is a nonprofit organization providing seed funding for early-stage brain cancer research through pilot grants that bridge the gap between scientific innovation and large-scale support. BeWonderNow is a recipient of the Innovators in Cancer Research Award. Learn more at bwnfoundation.com.

BeWonderNow, Inc. Opens Spring 2026 Pilot Grant Applications for Brain Cancer Research

BeWonderNow Inc. Spring Pilot Grant Cycle Open

BeWonderNow, Inc. is now accepting applications for its Spring 2026 Pilot Grant Program, providing seed funding for innovative, early-phase brain cancer research at accredited U.S. institutions.

The program awards between $25,000 and $150,000 in direct costs per project, supporting physician-scientists and researchers generating the critical preliminary data that opens the door to larger federal and industry funding. Project durations typically run 12 to 24 months, with indirect costs allowed up to 10%.

“We exist to fund the ideas that are too early for the NIH but too important to wait,” said Sandi Wewerka of BeWonderNow, Inc. “Brain cancer patients and families cannot afford a gap between bold scientific thinking and the resources to pursue it.”

Spring 2026 Submission Deadlines

  • Letter of Intent: May 8, 2026
  • Full Proposal: June 8, 2026
  • Funding Decision Announcement: July 13, 2026

All applicants must submit a one-page Letter of Intent prior to a full proposal. The LOI process allows the BeWonderNow Board of Directors — a multidisciplinary group of physician-scientists and researchers — to evaluate alignment with the foundation’s mission before requesting a complete application. Applicants are notified of their invitation status within five business days of LOI submission.

Eligible applicants must be affiliated with an accredited academic, medical, or research institution within the United States. Proposed research must focus on innovative, early-phase brain cancer research with strong scientific rationale and meaningful potential to advance discovery.

Full proposal requirements include a five-page proposal, budget and budget justification, NIH biosketches for all key personnel, a cover letter, and an AI use statement.

For complete grant guidelines, eligibility requirements, and submission instructions, visit bwnfoundation.com/grant-information.

Questions about eligibility or mission alignment should be directed to Sandi Wewerka at sandi@1246750.us16.myftpupload.com or 651-357-3679.

BeWonderNow, Inc. is a nonprofit organization providing seed funding for early-stage brain cancer research through pilot grants that bridge the gap between innovation and large-scale support. Learn more at bwnfoundation.com.

Be Wonder Now: Fueling Breakthroughs in Brain Cancer Research

woman in white coat holding black dslr camera

Brain cancer remains one of the most challenging diseases to treat, with limited treatment options and a long road ahead toward a cure. But thanks to the tireless work of nonprofit organizations like Be Wonder Now, there is new hope for researchers, patients, and families alike.

Founded on the belief that curiosity and compassion can drive meaningful change, Be Wonder Now has quickly become a vital supporter of innovative brain cancer research. Through their grant program, they are empowering scientists and medical teams to pursue bold ideas that traditional funding sources often overlook.

Supporting Bold, Innovative Research

While government and large institutional funding often go to projects with proven results, Be Wonder Now takes a different approach. Their mission is to back high-risk, high-reward research—the kind that could redefine how brain tumors are diagnosed, treated, and ultimately cured. By offering targeted grants to promising projects, the foundation is helping accelerate discoveries that could have a profound impact.

One of their most recent grant cycles funded research into precision therapies that use genetic mapping to identify the unique mutations driving tumor growth. Another grant supported the exploration of advanced imaging techniques that may allow doctors to detect brain tumors earlier and more accurately. These efforts are not just theoretical—they’re paving the way for real advancements in patient care.

A Community of Hope

Be Wonder Now is more than just a funding source—it’s a community. Families affected by brain cancer, survivors, and supporters are all part of the mission. Through storytelling and outreach, the foundation highlights the resilience of those fighting brain cancer while reminding us of the urgent need for continued research.

Their name, Be Wonder Now, reflects their philosophy: to embrace curiosity, ask the hard questions, and act with compassion in the present moment. This spirit of wonder fuels their commitment to backing researchers who dare to imagine a future free from brain cancer.

Looking Ahead

As Be Wonder Now continues to expand its grantmaking, the foundation is actively seeking to partner with more institutions, researchers, and advocates. Each grant represents not just funding, but a powerful belief in the potential of science to change lives.

For families touched by brain cancer, organizations like Be Wonder Now represent something priceless: hope. Hope that the next big discovery is just around the corner. Hope that researchers will have the resources they need to keep moving forward. And hope that one day, a diagnosis of brain cancer will no longer be a life sentence.

✨ To learn more about Be Wonder Now’s mission and the groundbreaking projects they support, visit their website and discover how you can get involved in fueling the future of brain cancer research.